Literature DB >> 20801901

Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity.

Philip A Thompson, Stephen Lade, Howard Webster, Gail Ryan, H Miles Prince.   

Abstract

Mesh:

Year:  2010        PMID: 20801901      PMCID: PMC2966924          DOI: 10.3324/haematol.2010.026237

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

Review 1.  Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  Plast Reconstr Surg       Date:  2009-03       Impact factor: 4.730

2.  Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy.

Authors:  Brunangelo Falini; Maria Paola Martelli
Journal:  Haematologica       Date:  2009-07       Impact factor: 9.941

Review 3.  Breast lymphoma associated with breast implants: two case-reports and a review of the literature.

Authors:  Guylaine Gaudet; Jonathan W Friedberg; Andrew Weng; Geraldine S Pinkus; Arnold S Freedman
Journal:  Leuk Lymphoma       Date:  2002-01

4.  Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.

Authors:  R D Gascoyne; P Aoun; D Wu; M Chhanabhai; B F Skinnider; T C Greiner; S W Morris; J M Connors; J M Vose; D S Viswanatha; A Coldman; D D Weisenburger
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

5.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

Review 6.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

7.  Anaplastic large-cell lymphoma in women with breast implants.

Authors:  Daphne de Jong; Wies L E Vasmel; Jan Paul de Boer; Gideon Verhave; Ellis Barbé; Mariel K Casparie; Flora E van Leeuwen
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

8.  Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction?

Authors:  Shiyong Li; Andrew K Lee
Journal:  Int J Clin Exp Pathol       Date:  2009-10-15

9.  Lymphomas of the breast. A clinicopathologic and immunohistochemical study of primary and secondary cases.

Authors:  P L Cohen; J J Brooks
Journal:  Cancer       Date:  1991-03-01       Impact factor: 6.860

10.  Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature.

Authors:  Roberto N Miranda; Lin Lin; Sameer S Talwalkar; John T Manning; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

View more
  20 in total

Review 1.  Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis.

Authors:  Philip A Thompson; H Miles Prince
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

2.  Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndrome.

Authors:  Yi-Shan Lee; Armando Filie; Diane Arthur; Antonio T Fojo; Elaine S Jaffe
Journal:  Histopathology       Date:  2015-06-18       Impact factor: 5.087

3.  Implant-associated anaplastic large cell lymphoma of the breast: Insight into a poorly understood disease.

Authors:  William M Weathers; Erik M Wolfswinkel; Daniel A Hatef; Edward I Lee; Larry H Hollier; Rodger H Brown
Journal:  Can J Plast Surg       Date:  2013

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  Primary anaplastic large-cell lymphoma associated with breast implants.

Authors:  Leslie Popplewell; Sandra H Thomas; Qin Huang; Karen L Chang; Stephen J Forman
Journal:  Leuk Lymphoma       Date:  2011-06-24

Review 6.  Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Authors:  Ryan C Lynch; Dita Gratzinger; Ranjana H Advani
Journal:  Curr Treat Options Oncol       Date:  2017-07

Review 7.  Breast Implant-Associated Lymphoma.

Authors:  Julian Kricheldorff; Eva Maria Fallenberg; Christine Solbach; Claudia Gerber-Schäfer; Christoph Rancsó; Uwe von Fritschen
Journal:  Dtsch Arztebl Int       Date:  2018-09-21       Impact factor: 5.594

8.  Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome.

Authors:  Anna K Engberg; Christopher G Bunick; Antonio Subtil; Christine J Ko; Michael Girardi
Journal:  J Clin Oncol       Date:  2012-11-26       Impact factor: 44.544

9.  Anaplastic large cell lymphoma associated with breast implant: a case report.

Authors:  Afsaneh Rajabiani; Hosein Arab; Abolhasan Emami; Ali Manafi; Navid Bazzaz; Hiva Saffar
Journal:  World J Plast Surg       Date:  2012-01

Review 10.  Breast implant-associated anaplastic large cell lymphoma: a review.

Authors:  Andrés E Quesada; L Jeffrey Medeiros; Mark W Clemens; Maria C Ferrufino-Schmidt; Sergio Pina-Oviedo; Roberto N Miranda
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.